EIF2AK4
MOLECULAR TARGETeukaryotic translation initiation factor 2 alpha kinase 4
EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) is targeted by 22 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting EIF2AK4
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | tozasertib | 4.33 | 75 |
| 3 | bosutinib | 4.08 | 58 |
| 4 | midostaurin | 3.85 | 46 |
| 5 | neratinib | 3.66 | 38 |
| 6 | nintedanib | 3.61 | 36 |
| 7 | pelitinib | 3.50 | 32 |
| 8 | tae 684 | 3.43 | 30 |
| 9 | fedratinib | 3.40 | 29 |
| 10 | dovitinib | 3.09 | 21 |
| 11 | jnj 7706621 | 3.09 | 21 |
| 12 | lestaurtinib | 3.04 | 20 |
| 13 | r 406 | 2.83 | 16 |
| 14 | pha 665752 | 2.71 | 14 |
| 15 | plx 4720 | 2.71 | 14 |
| 16 | kw 2449 | 2.64 | 13 |
| 17 | raf 265 | 2.48 | 11 |
| 18 | motesanib | 2.48 | 11 |
| 19 | gsk 461364 | 2.40 | 10 |
| 20 | su 014813 | 2.20 | 8 |
| 21 | ly 3009120 | 2.08 | 7 |
| 22 | Dasatinib | 0.69 | 1 |
About EIF2AK4 as a Drug Target
EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 22 compounds with documented EIF2AK4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
EIF2AK4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.